Skip to main content
Premium Trial:

Request an Annual Quote

Suit Over a Marker

A biotech company is suing a prostate cancer researcher for making false claims concerning a disease biomarker, reports Science Insider. According to the Pittsburgh Tribune-Review, Robert Getzenberg, then at University of Pittsburgh and now at Johns Hopkins University, he found a biomarker, EPCA-2, for human prostate cancer that he and the University of Pittsburgh patented it. The biotech company Onconome then spent millions of dollars to research, produce, and market a test based on that patent before discovering that the protein was only mapped in rats, not humans. "Notwithstanding the spectacular (and false) results proclaimed by defendants, the Getzenberg assay was no more accurate in distinguishing cancerous tissue from normal tissue than flipping a coin," the lawsuit says.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.